Editas Medicine, Inc. engages in the development and commercialization of genome editting technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.^ ^ ^
Market Cap | 755.079 Million | Shares Outstanding | 68.519 Million | Avg 30-day Volume | 1.784 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.67 |
Price to Revenue | 70.2824 | Debt to Equity | 0.0 | EBITDA | -189.791 Million |
Price to Book Value | 3.2427 | Operating Margin | -756.1306 | Enterprise Value | 1.175 Billion |
Current Ratio | 10.821 | EPS Growth | -0.429 | Quick Ratio | 10.667 |
1 Yr BETA | 2.2304 | 52-week High/Low | 73.03 / 9.71 | Profit Margin | -753.6095 |
Operating Cash Flow Growth | 8.9189 | Altman Z-Score | 6.8298 | Free Cash Flow to Firm | -187.116 Million |
Earnings Report | 2022-08-03 |
Please sign in first
none
1.6 Thousand total shares from 2 transactions
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
EATON BRUCE EVP, CHIEF BUSINESS OFFICER |
|
66,544 | 2022-05-09 | 8 |
MULLEN JAMES C CEO |
|
170,989 | 2022-04-14 | 6 |
ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
|
84,194 | 2022-03-03 | 6 |
SHEARMAN MARK S EVP, CHIEF SCIENTIFIC OFFICER |
|
166,892 | 2022-02-10 | 4 |
MICHAELS LISA ANNE EVP/CHIEF MEDICAL OFFICER |
|
22,675 | 2021-12-22 | 2 |
|
0 | 2021-10-26 | 2 | |
|
0 | 2021-09-03 | 2 | |
|
11,538 | 2021-06-03 | 1 | |
|
11,538 | 2021-06-03 | 1 | |
|
11,538 | 2021-06-03 | 1 | |
|
11,538 | 2021-06-03 | 1 | |
|
11,538 | 2021-06-03 | 1 | |
COLLINS CYNTHIA CEO |
|
43,760 | 2021-02-09 | 0 |
ALBRIGHT CHARLES EVP/CHIEF SCIENTIFIC OFFICER |
|
24,907 | 2020-12-15 | 0 |
ABRAMS JUDITH R CHIEF MEDICAL OFFICER |
|
25,000 | 2019-10-28 | 0 |
MYER VICKESH CHIEF TECHNOLOGY OFFICER |
|
0 | 2019-03-18 | 0 |
EK ERIC INTERIM CFO |
|
0 | 2019-03-01 | 0 |
HACK ANDREW A. F. CHIEF FINANCIAL OFFICER |
|
0 | 2019-02-04 | 0 |
BOSLEY KATRINE PRESIDENT AND CEO |
|
1,204,966 | 2019-01-08 | 0 |
|
0 | 2018-06-15 | 0 | |
COX GERALD FRANK CHIEF MEDICAL OFFICER |
|
0 | 2018-02-07 | 0 |
|
3,171 | 2017-08-17 | 0 | |
|
0 | 2017-06-15 | 0 | |
|
0 | 2017-06-15 | 0 | |
|
0 | 2017-06-15 | 0 | |
GLUCKSMANN ALEXANDRA CHIEF OPERATING OFFICER |
|
117,788 | 2017-03-15 | 0 |
POLARIS VENTURE MANAGEMENT CO. VI, L.L.C. |
|
3,797,144 | 2016-12-07 | 0 |
|
3,906,176 | 2016-09-06 | 0 | |
|
3,906,176 | 2016-08-16 | 0 | |
FLAGSHIP VENTURES FUND IV, L.P. FLAGSHIP VENTURES FUND IV-RX, L.P. |
|
No longer subject to file | 2016-08-11 | 0 |
DEERFIELD PRIVATE DESIGN FUND III, L.P. |
|
No longer subject to file | 2016-02-08 | 0 |
|
2,040,814 | 2016-02-08 | 0 | |
VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC |
|
No longer subject to file | 2016-02-08 | 0 |
|
No longer subject to file | 2016-02-08 | 0 | |
|
480,769 | 2016-02-02 | 0 | |
|
480,769 | 2016-02-02 | 0 | |
|
480,769 | 2016-02-02 | 0 | |
|
480,769 | 2016-02-02 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-05-11 16:15:36 -0400 | 2022-05-09 | S | 297 | $13.11 | d | 66,544 | direct | 9.8057 | 1.2026 | 9.8057 | 2 | -0.8326 | 5 | |||
2022-04-18 16:15:11 -0400 | 2022-04-14 | A | 170,989 | a | 170,989 | direct | ||||||||||
2022-04-04 16:30:15 -0400 | 2022-04-01 | S | 1,258 | $19.64 | d | 66,841 | direct | -2.8529 | -11.9528 | -47.27 | 0.0 | 1 | -50.664 | 26 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
EDITAS MEDICINE INC EDIT | 2022-05-20 22:15:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 21:45:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 21:15:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 20:45:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 20:15:05 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 19:45:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 19:15:04 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 18:45:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 18:15:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 17:45:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 17:15:03 UTC | 0.2477 | 0.5723 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 16:45:04 UTC | 0.2603 | 0.5597 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 16:15:03 UTC | 0.2603 | 0.5597 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 15:45:03 UTC | 0.2603 | 0.5597 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 15:15:03 UTC | 0.2603 | 0.5597 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 14:45:03 UTC | 0.5185 | 0.3015 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 14:15:04 UTC | 0.5185 | 0.3015 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 13:45:03 UTC | 0.5185 | 0.3015 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 13:15:03 UTC | 0.5185 | 0.3015 | 1600000 |
EDITAS MEDICINE INC EDIT | 2022-05-20 12:45:03 UTC | 0.5185 | 0.3015 | 1600000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
FundVantage Trust- Gotham Enhanced Index Plus Fund | EDIT | -134.0 shares, $-2657.22 | 2020-03-31 | N-PORT |
FundVantage Trust- Gotham Defensive Long Fund | EDIT | -93.0 shares, $-1844.19 | 2020-03-31 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | EDIT | -154.0 shares, $-3053.82 | 2020-03-31 | N-PORT |
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund | EDIT | -1156.0 shares, $-48390.16 | 2021-07-31 | N-PORT |